Journal
AUSTRALASIAN JOURNAL OF DERMATOLOGY
Volume 63, Issue 2, Pages E155-E158Publisher
WILEY
DOI: 10.1111/ajd.13803
Keywords
bullous pemphigoid; immunobullous; interleukin-17; monoclonal antibody; psoriasis
Categories
Ask authors/readers for more resources
This case report demonstrates the first case of secukinumab achieving a dramatic clinical improvement of both chronic psoriasis and active BP.
Since the concurrence of bullous pemphigoid (BP) and psoriasis was first reported in 1929, an increasing number of studies has been published to analyse their relationship in recent years. However, the pathogenesis of the concurrence is not yet well understood, and the coexistence of the two conditions imposes a difficult therapeutic challenge. This case report demonstrates the first case of secukinumab achieving a dramatic clinical improvement of both chronic psoriasis and active BP.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available